Similarly, the knockdown of PGM1 resulted in a decrease in the cell viability of glioma cells; furthermore, in glioblastoma xenografts the knockdown of PGM1 led to an increment of 14.5% in the survival rate of the mice [127]. This evidence concerns the gene PGM1 and glioma.